New yellow fever vaccine shows promise in early trial
NCT ID NCT04142086
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tested a new yellow fever vaccine in 73 healthy adults aged 18 to 60. Researchers checked for side effects and measured how well the vaccine triggered an immune response over 6 months. The goal was to find the safest and most effective dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YELLOW FEVER (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 8400001
Silver Spring, Maryland, 20910, United States
Conditions
Explore the condition pages connected to this study.